Endocrinologist and Mater Researcher David McIntyre has been conferred the title of Emeritus Professor in recognition of his outstanding commitment and contribution to The University of Queensland. 

Mater Research hosted the 2023 Future Leaders Symposium at the Translational Research Institute (TRI) this week.

Pregnant women with diabetes will be able to enjoy midwifery-led care for the first time thanks to an Australian-first model of care being launched by Mater Mothers’ Hospital.

The first Australian trial of a new COVID medication that is set to save the lives of vulnerable immuno-suppressed patients has been launched in Brisbane.

Dr Jay Gunawardana and Dr Joshua Tobin, members of Mater Research's Blood Cancer Group led by Professor Maher Gandhi, have recently been awarded more than $375,000 in funding to further their...

Scientists at Mater Research and The University of Queensland have recently identified a potential treatment to enhance the healing of fractures among osteoporosis sufferers.

A ground-breaking Mater Research project will place health workers in Indigenous communities across Queensland and study the long-term wellbeing of 400 Aboriginal and Torres Strait Islander...

A team of clinician-based Mater Researchers are leading the way launching a new Australian-first innovative model of care for pregnant women with diabetes.

We are delighted to announce that Mater Researcher, Jen Stables, a final year PhD student in the Macrophage Biology Research Group was a finalist in both the Judges’ Award and the Breaking Barriers...

More children are getting Type 1 diabetes and Mater Researcher Professor Jo Forbes is working to find out, “why?” 

A Mater clinic dedicated to pregnant women with small babies is helping to prevent stillbirth and other newborn complications.

A team of Queensland researchers at Mater Mothers’ Hospital Brisbane are trialling a new Respiratory Syncytial Virus (RSV) vaccine that could deliver single dose protection and reduce...